Albert Huang, M.D.
As the Innovation Strategist, Albert focuses on supporting the TMCx resident companies as they develop their groundbreaking healthcare technologies. He is responsible for guiding and introducing the companies to the right resources and groups within the Texas Medical Center, and to help foster the rapidly developing TMC medtech ecosystem.
He has trained at world class institutions and under world renowned surgeons during his career. His undergraduate degree in Cell and Developmental was at the University of Rochester and then he trained in Tissue Engineering under Dr. Joseph Vacanti at Harvard before medical school at the University of Texas Health Science Center in San Antonio. He moved to Houston for general surgery training at Houston Methodist/Weill Cornell before transitioning full time in the field of medtech innovation when he founded Allotrope Medical, a medical device company, based on a need he identified in the operating room.
Through his medtech experience and as the CEO of Allotrope Medical, Albert has been awarded National Science Foundation grant funding, received accolades and awards both in the surgical (taking Top Innovation at SAGES 2017) as well as the medtech community (Featured multiple times in The Medtech Strategist, and coming in second place during Medtech Innovator). He is also the only physician in Houston to have his company accepted into Y-Combinator.
Albert has over a decade of entrepreneurial and innovation experience both in and out of the medical field, and is always excited and willing to share the lessons he’s learned with others pursuing the path of innovation.